GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies.

For EXSCEL, while the point estimate for MACE reduction was favourable (HR 0.91), it did not reach statistical significance, a result potentially confounded by high rates of treatment discontinuation and the inclusion of a relatively lower-risk population [ 17 , 65 ].

also in 111,027 other papers